HomeTagsClaudin 18.2

Claudin 18.2

Healthcare

Innovent Announces First Patient Dosing of Universal “Modular” CAR-T Cell product IBI345

PR Newswire - February 21, 2022

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune...

Hot Topics

Quantum Computing Inc. Secures NASA Contract for Dirac-3 Photonic Solver

Syntiant Acquires Knowles’ Consumer MEMS Microphone Division

OneView Enhances Omnichannel Fulfillment with New Features